Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

AB3230

Sigma-Aldrich

Anti-Low Density Lipoprotein Antibody, copper oxidized

serum, Chemicon®

Sinónimos:

LDL

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Código UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.41

origen biológico

rabbit

Nivel de calidad

forma del anticuerpo

serum

tipo de anticuerpo

primary antibodies

clon

polyclonal

reactividad de especies

human

fabricante / nombre comercial

Chemicon®

técnicas

ELISA: suitable
immunohistochemistry: suitable
western blot: suitable

Condiciones de envío

wet ice

modificación del objetivo postraduccional

unmodified

Información sobre el gen

human ... LDLR(3949)

Especificidad

Reacts strongly to fully oxidatized modifications of LDL including Cu2+-oxidized LDL, MDA-LDL, HOCL-LDL but not to other oxidized proteins like MDA-HSA, HOCL-HSA, MDA-HDL, HOCL-HDL (below detection limit). The reaction of native LDL was weak, but clearly detectable (approx. 20%). Minimally oxidized LDL gave a strong binding signal (>80%).

Inmunógeno

Epitope: copper oxidized
Fully Cu2+-oxidized LDL.

Aplicación

Anti-Low Density Lipoprotein Antibody, copper oxidized is an antibody against Low Density Lipoprotein for use in ELISA, WB, IH.
Research Category
Metabolism
Research Sub Category
Lipid Metabolism & Weight Regulation
Western Blot

Immunohistochemistry: 1:50-1:500

ELISA: 1:500-1:5,000

Optimal working dilutions must be determined by the end user.

Forma física

Rabbit serum. Lyophilized. Contains no preservative. Reconstitute with 100 μL of sterile distilled water.

Almacenamiento y estabilidad

Maintain lyophilized material at 2-8°C for up to 12 months. After reconstitution maintain at -20°C in undiluted aliquots for up to 6 months. Avoid repeated freeze/thaw cycles.

Información legal

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Cláusula de descargo de responsabilidad

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

¿No encuentra el producto adecuado?  

Pruebe nuestro Herramienta de selección de productos.

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 1

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable


Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Deepa Sankaran et al.
Nephron. Experimental nephrology, 106(4), e122-e128 (2007-07-12)
Dietary soy protein and flax oil retard kidney disease progression when initiated in the early stages of disease in several experimental models, including the Han:SPRD-cy rat. However, individuals with kidney disease often do not become aware of their condition until
Malcolm R Ogborn et al.
Lipids, 43(9), 783-791 (2008-07-17)
Conjugated linoleic acid (CLA) is anti-proliferative and anti-inflammatory in the Han:SPRD-cy rat model of kidney disease. We used different doses of CLA and examined effects on renal histological benefit, the renal PPARgamma system and hepatic and renal levels of CLA
Dietary soya protein during pregnancy and lactation in rats with hereditary kidney disease attenuates disease progression in offspring.
Cahill, LE; Peng, CY; Bankovic-Calic, N; Sankaran, D; Ogborn, MR; Aukema, HM
The British Journal of Nutrition null
Deficiency in the metabolite receptor SUCNR1 (GPR91) leads to outer retinal lesions.
Favret, S; Binet, F; Lapalme, E; Leboeuf, D; Carbadillo, J; Rubic, T; Picard, E; Mawambo et al.
Aging null
Tadashi Uramatsu et al.
Biological & pharmaceutical bulletin, 36(8), 1271-1277 (2013-08-02)
Stroke-prone spontaneously hypertensive (SHRsp) rats develop severe hypertension resulting in renal injury. We investigated apoptosis inhibitor of macrophages (AIM) expression in nephrosclerotic rats and the involvement of AIM in olmesartan (OLM)- and azelnidipine (AZN)-induced decreases in the number of macrophages

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico